Latest Private Equity News

CD Private Equity Fund I (ASX:CD1) posted a net loss of $6.96 million for the year ended 31 March 2026, driven by a $5.14 million fair value decline in its US private equity holdings and significant foreign exchange pressures. Despite near-term setbacks, the Fund has delivered an 8.3% post-tax annual return since inception.

CD Private Equity Fund III (ASX:CD3) posted a net loss of $9.01 million for FY26, weighed down by foreign exchange losses and fair value declines. Despite near-term challenges, the Fund sustains strong long-term performance and liquidity.

Bailador Technology Investments has increased the valuations of PropHero and MOSH, driving a 4.3 cent pre-tax NTA per share uplift, while fully writing down its investment in Nosto following weaker trading.

North Stawell Minerals (ASX:NSM) has reinforced its position in Victoria’s gold scene with strong drilling results and an updated 87,300-ounce resource at Wildwood, leveraging advanced geophysical techniques to unlock potential beneath cover.

Pengana Private Equity Trust (ASX:PE1) estimates its net asset value could jump by about AU$79 million after SpaceX's Nasdaq debut, lifting NAV per unit by roughly AU$0.29 based on mid-June pricing.

Argent Minerals appoints mining veteran Mike McKevitt as CEO to spearhead advancement of its flagship Kempfield Silver Project and evaluate growth across gold and copper assets.

XPON Technologies is selling its Google Marketing Platform and Cloud Platform business to Incubeta for an initial A$5.5 million cash plus up to A$2 million earn-out, aiming to accelerate growth in its Wondaris AI Marketing Platform and fund AI-focused acquisitions.

Microba Life Sciences secures $5 million in a placement led by Sonic Healthcare to fund its push towards cashflow break-even by 2027, backed by strong diagnostic sales and AI-driven efficiencies.

oOh!media is actively engaging with several financial sponsors, including Bain Capital, Pacific Equity Partners, and I Squared Capital, over potential change of control deals, having received conditional non-binding indicative offers.

Australian Clinical Labs appoints Greg Horan as Group CEO effective August 2026, marking a leadership transition after a decade under Melinda McGrath. Horan’s healthcare and operational expertise positions ACL for its next growth phase.

Maronan Metals has completed a $22 million strategic placement with Kinterra Capital, which now holds nearly 20% of the company. The funds will accelerate an expanded 2026 drilling campaign and Preliminary Feasibility Study for the Maronan Project in Queensland.

Maronan Metals has landed a $22 million strategic investment from Kinterra Capital, boosting its cash reserves to $36.6 million and fully funding an expanded 2026 drilling campaign and Preliminary Feasibility Study for its Maronan Project.